Related Experiment Videos
Plasma lipids in extra hepatic biliary obstruction
Summary
Extra hepatic biliary obstruction (EHO) causes significant, persistent hypertriglyceridemia, distinct from endogenous forms. Lipid profiles normalize after obstruction relief, though Lipoprotein-X may persist.
Area of Science:
- Biochemistry
- Clinical Medicine
- Lipid Metabolism
Background:
- Extra hepatic biliary obstruction (EHO) is associated with altered plasma lipid profiles.
- Previous studies suggested hypertriglyceridemia in EHO, but its consistency and significance required further investigation.
Purpose of the Study:
- To investigate the extent and consistency of hypertriglyceridemia in patients with EHO.
- To compare plasma lipid and lipoprotein changes in EHO patients before and after surgical relief of obstruction.
- To differentiate EHO-associated hypertriglyceridemia from endogenous (type IV) hypertriglyceridemia.
Main Methods:
- Analysis of plasma lipids and lipoproteins in 15 patients with EHO and 23 controls.
- Comparison of lipid profiles before and after surgical intervention for EHO.
- Electrophoretic analysis of lipoproteins and assessment of cold aggregation tests.
Main Results:
- Patients with EHO exhibited increased total cholesterol (unesterified fraction), phospholipids, and a marked, persistent elevation in triglycerides.
- Triglyceride levels in EHO were comparable in magnitude to cholesterol and phospholipid increases and normalized post-obstruction relief.
- EHO-associated hypertriglyceridemia presented with clear serum, negative cold aggregation, and a broad beta fraction, differing from type IV hypertriglyceridemia.
- Lipoprotein-X was detected in EHO patients and persisted even after other lipid parameters normalized.
Conclusions:
- Extra hepatic biliary obstruction consistently causes significant hypertriglyceridemia, characterized by specific lipoprotein changes.
- The hypertriglyceridemia in EHO is reversible upon relief of obstruction, unlike certain other lipid abnormalities.
- Lipoprotein-X is a persistent marker associated with EHO, even when other lipid parameters return to normal.